TITLE

Identification of novel regulators in T-cell differentiation of aplastic anemia patients

AUTHOR(S)
Franzke, Anke; Geffers, Robert; Hunger, J Katrin; Pfortner, Susanne; Piao, Wenji; Ivanyi, Philipp; Grosse, Jens; Probst-Kepper, Michael; Ganser, Arnold; Buer, Jan
PUB. DATE
January 2006
SOURCE
BMC Genomics;2006, Vol. 7, p263
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Aplastic anemia (AA) is a bone marrow failure syndrome mostly characterized by an immune-mediated destruction of marrow hematopoietic progenitor/stem cells. The resulting hypocellularity limits a detailed analysis of the cellular immune response. To overcome this technical problem we performed a microarray analysis of CD3+ T-cells derived from bone marrow aspirates and peripheral blood samples of newly diagnosed AA patients and healthy volunteers. Two AA patients were additionally analyzed after achieving a partial remission following immunosuppression. The regulation of selected candidate genes was confirmed by real-time RTPCR. Results: Among more than 22.200 transcripts, 583 genes were differentially expressed in the bone marrow of AA patients compared to healthy controls. Dysregulated genes are involved in T-cell mediated cytotoxicity, immune response of Th1 differentiated T-cells, and major regulators of immune function. In hematological remission the expression levels of several candidate genes tend to normalize, such as immune regulators and genes involved in proinflammatory immune response. Conclusion: Our study suggests a pivotal role of Th1/Tc1 differentiated T-cells in immunemediated marrow destruction of AA patients. Most importantly, immune regulatory genes could be identified, which are likely involved in the recovery of hematopoiesis and may help to design new therapeutic strategies in bone marrow failure syndromes.
ACCESSION #
28858716

 

Related Articles

  • Using Wind Tunnels to Predict Bird Mortality in Wind Farms: The Case of Griffon Vultures. de Lucas, Manuela; Ferrer, Miguel; Janss, Guyonne F. E. // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Background: Wind farms have shown a spectacular growth during the last 15 years. Avian mortality through collision with moving rotor blades is well-known as one of the main adverse impacts of wind farms. In Spain, the griffon vulture incurs the highest mortality rates in wind farms....

  • Alteration in Marrow Stromal Microenvironment and Apoptosis Mechanisms Involved in Aplastic Anemia: An Animal Model to Study the Possible Disease Pathology. Chatterjee, Sumanta; Dutta, Ranjan Kumar; Basak, Pratima; Das, Prosun; Das, Madhurima; Pereira, Jacintha Archana; Chaklader, Malay; Chaudhuri, Samaresh; Law, Sujata // Stem Cells International;2010, p1 

    Aplastic anemia (AA) is a heterogeneous disorder of bone marrow failure syndrome. Suggested mechanisms include a primary stem cell deficiency or defect, a secondary stem cell defect due to abnormal regulation between cell death and differentiation, or a deficient microenvironment. In this study,...

  • Function and Malfunction of Hematopoietic Stem Cells in Primary Bone Marrow Failure Syndromes. Risitano, Antonio M.; Maciejewski, Jaroslaw P.; Selleri, Carmine; Rotoli, Bruno // Current Stem Cell Research & Therapy;Jan2007, Vol. 2 Issue 1, p39 

    Hematopoietic stem cells (HSCs) are responsible for the production of mature blood cells in bone marrow; peripheral pancytopenia is a common clinical presentation resulting from several different conditions, including hematological or extra-hematological diseases (mostly cancers) affecting the...

  • FREQUENCY OF APLASTIC ANAEMIA IN CHILDREN. Ayub, Tariq; Khan, Fazal ur Rahman; Mahsud, Muhammad Amin Jan // Gomal Journal of Medical Sciences;Jan2011, Vol. 9 Issue 1, p62 

    Background: Aplastic anaemia is a rare haematopoetic stem cell disorder. The aetiology of the acquired aplastic anaemia is most of the times unknown. The blood count reveals decrease in either or all the cell lines and bone marrow is hypocellular. Objective of this study was to find out the...

  • Uncontrolled triggering of programmed cell death (apoptosis) in haematopoietic stem cells: A new hypothesis for the pathogenesis of aplastic anaemia. Laveder, Francesco; Marcolongo, Renzo // Immunology & Cell Biology;Apr1996, Vol. 74 Issue 2, p159 

    The cause of bone marrow failure in aplastic anaemia (AA) is still unknown: however, it is clear that acquired AA is a heterogeneous disease including basically different pathophysiological conditions. Causative agents, clinically associated with AA, possibly exert their action through...

  • Functional Analysis of Telomerase Mutations in Dyskeratosis Congenita. Johnson, Katherine Taneille; Beattie, Tara L. // Canadian Young Scientist Journal;2011, Vol. 2011 Issue 2, p39 

    Telomerase is a ribonucleoprotein enzyme that functions in maintaining and elongating telomeres[1]. Mutations in telomerase (hTERT) have been identified and linked to hematological disease states such as Aplastic anemia, Dyskeratosis congenita (DKC), and Acute myeloid leukemia[2,3]. It is...

  • A novel autologous stem cell procedure for the treatment of aplastic anaemia using reprogrammed mature adult cells: a pilot study. Abuljadayel, Ilham Saleh; Mohanty, Dipika; Suri, Rajendar K. // Indian Journal of Medical Research;Jun2012, Vol. 135 Issue 6, p853 

    Background & objectives: Aplastic anaemia is a life threatening rare bone marrow failure disorder. The underlying haematopoietic cellular deficit leads to haemorrhage, infection and severe anaemia. The treatment of choice for this haematological condition is allogeneic bone marrow...

  • Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations. Niimi, H.; Harada, H.; Harada, Y.; Ding, Y.; Imagawa, J.; Inaba, T.; Kyo, T.; Kimura, A. // Leukemia (08876924);Apr2006, Vol. 20 Issue 4, p635 

    AML1/RUNX1 mutations have been reported frequently in myelodysplastic syndrome (MDS) patients, especially those diagnosed with refractory anemia with excess blast (RAEB), RAEB in transformation (RAEBt), or AML following MDS (these categories are defined as MDS/AML). Although AML1 mutations are...

  • Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Strahm, B.; Nöllke, P.; Zecca, M.; Korthof, E. T.; Bierings, M.; Furlan, I.; Sedlacek, P.; Chybicka, A.; Schmugge, M.; Bordon, V.; Peters, C.; O'Marcaigh, A.; de Heredia, C. D.; Bergstraesser, E.; Moerloose, B. D.; van den Heuvel-Eibrink, M. M.; Starý, J.; Trebo, M.; Wojcik, D.; Niemeyer, C. M. // Leukemia (08876924);Mar2011, Vol. 25 Issue 3, p455 

    We report on the outcome of children with advanced primary myelodysplastic syndrome (MDS) transplanted from an HLA-matched sibling (MSD) or an unrelated donor (UD) following a preparative regimen with busulfan, cyclophosphamide and melphalan. Ninety-seven patients with refractory anemia with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics